Description We would like to hear your feedback. Please share here. Once considered a rare inherited condition, HCM is now known to affect 1 in 200 to 1 in 500 people, yet it remains mostly undiagnosed 1-4 Echoes of change brings you an interactive, case-led discussion that dives deep into the real-world complexities of HCM. Featuring both global and national experts, this session will: Uncover key diagnostic challenges Share Global and Indian clinical perspectives on evolving landscape in management of oHCM Share clinical insights on targeted therapies like mavacamten for symptomatic oHCM Join us to sharpen your clinical perspective, bridge global-local insights, and be part of the conversation that’s shaping the future of HCM care. ##References## Desai MY, Owens A, Wolski K, et al.
JAMA cardiology. 2023 Oct 1;8(10):968-77. Butzner M, et al. Front Cardiovasc Med.…
